Competa, Radzmer .

HRN: 27-70-42  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/28/2025
CEFUROXIME 1.5GM (VIAL)
08/28/2025
09/04/2025
IV
650 Mg
Q8h
T/c Intussusception
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines